Contact Us
Investor/Media Information
View contact details for Investor Relations and Media Relations representatives.
U.S. Adverse Event Reporting
Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding TYSABRI® (natalizumab), please contact Biogen Idec at 1-866-MED-INFO (1-866-633-4636) or by e-mail at medinfo@biogenidec.com
Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding PRIALT® (ziconitide intrathecal infusion), please contact Jazz Pharmaceuticals at 1-888-774-2581.
Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding MAXIPIME® (cefepime hydrochloride, USP) for Injection or AZACTAM® (aztreonam for injection, USP), please contact Bristol Myers Squibb Medical Information (BMS) at 1-800-321-1335 or by email at Drug.Information@bms.com.
Locations
HeadquartersTreasury Building, Lower Grand Canal Street, Dublin 2, Ireland
TEL (353) 1 709 4000, FAX (353) 1 709 4700
300 Technology Square, Third Floor, Cambridge, MA 02139
TEL (800) 252 3526, FAX (617) 715 8281
Dammstrasse 19, CH-6301, Zug, Switzerland
TEL (41) 41 723 29 30, Fax (41) 41 723 29 40
Your feedback is helpful in determining the types of information you would be interested in seeing. Please submit your feedback to website.feedback@elan.com. Do not use the feedback e-mail address to report adverse events (side effects). Please see the Adverse Event Reporting section above.
U.S. Healthcare Professionals
Medical Information Services
For Medical Information, please click here
Careers/Job Opportunities
Search for a job with Elan.
